VeriMomIst sodium chitosan caprylamide hydroxypropylsulfonate in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
Related ingredients
Frequently asked questions
- Ist sodium chitosan caprylamide hydroxypropylsulfonate in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
- Ist sodium chitosan caprylamide hydroxypropylsulfonate während des Stillens sicher?
- No evidence of reproductive or lactation toxicity; no data suggesting systemic absorption in adults or transfer into breast milk. No harmonised CLP flags or CIR/SCCS concerns were identified. Therefore default low hazard and negligible exposure for breastfeeding mothers from topical cosmetic use.
- Ist sodium chitosan caprylamide hydroxypropylsulfonate sicher für Babyhaut?
- No infant‑specific reproductive or systemic toxicity data were identified. The ingredient is a high‑molecular‑weight chitosan derivative and likely shows limited skin penetration, but infant skin barrier immaturity and higher surface‑area‑to‑weight justify an exposure score increased by +1 relative to adults. No evidence was found to increase hazard or mechanism scores for infants.
- Wie bewertet VeriMom sodium chitosan caprylamide hydroxypropylsulfonate?
- VeriMom bewertet sodium chitosan caprylamide hydroxypropylsulfonate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu sodium chitosan caprylamide hydroxypropylsulfonate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu sodium chitosan caprylamide hydroxypropylsulfonate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.